Pasithea Therapeutics Corp.
Pharmaceutical company · Miami Beach, Florida, United States · Nasdaq: KTTA
Pasithea Therapeutics Corp. is a pharmaceutical company headquartered in Miami Beach, Florida, United States. Its earliest recorded incorporation is in 2020. Its shares trade on Nasdaq under the ticker KTTA. It has reported private securities offerings to the US SEC, most recently $30 million sold in a notice filed in 2021.
Pasithea Therapeutics at a glance
What does Pasithea Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $30.4 million sold (2021).
Frequently asked questions about Pasithea Therapeutics
Where is Pasithea Therapeutics headquartered?
Pasithea Therapeutics Corp. is headquartered in Miami Beach, Florida, United States.
What does Pasithea Therapeutics do?
Pasithea Therapeutics Corp. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Pasithea Therapeutics a public company?
Yes. Pasithea Therapeutics Corp. trades on Nasdaq under the ticker KTTA.
When was Pasithea Therapeutics founded?
The earliest incorporation on record for Pasithea Therapeutics Corp. is in 2020, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences